EODData

MEMBERSHIP REGISTER LOG IN

FRA, NP5: NEWRON PHARMACEUT. EO-20

22 Oct 2026
LAST:

9.080

CHANGE:
 0.38		OPEN:
9.080		HIGH:
9.080		ASK:
0.000		VOLUME:
0
CHG(%):
4.02		PREV:
9.460		LOW:
9.080		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Oct 269.0809.0809.0809.0800
21 Oct 268.9809.4608.9809.46010
20 Oct 268.6008.9608.6008.9600
19 Oct 268.6208.6208.6208.6200
16 Oct 268.6409.0608.6409.0600
15 Oct 268.2408.6008.2408.600800
13 Oct 268.8408.8408.3408.340500
12 Oct 267.8607.8607.8607.8601.8K
09 Oct 267.6207.9607.6207.9602.0K
08 Oct 266.7007.7006.5007.7002.0K

PROFILE

Name:NEWRON PHARMACEUT. EO-20
About:Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company's lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. The company was founded in 1999 and is headquartered in Bresso, Italy.
Sector:Healthcare
Industry:Biotechnology
Address:Via Antonio Meucci 3, Bresso, MI, Italy, 20091
Website:https://www.newron.com
ISIN:IT0004147952
LEI:8156002F8C11F80A9740

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:12.54 
Forward P/E:27.10 
Price to Sales:16.37 
Price to Book:324.05 
Profit Margin:-2.84 
Operating Margin:-5.21 
Return on Assets:-0.28 
Return on Equity:1.19 
Revenue:10.42M 
Shares:19.96M 
Market Cap:181.23M 

TECHNICAL INDICATORS

MA5:9.040.5%
MA10:8.566.0%
MA20:8.734.0%
MA50:11.0621.9%
MA100:12.0833.1%
MA200:16.0576.8%
STO9:76.25
STO14:78.41
RSI14:56.10
WPR14:-21.59
MTM14:0.56
ROC14:0.07 
ATR:0.43 
Week High:9.464.2%
Week Low:8.2410.2%
Month High:12.0032.2%
Month Low:6.5076.8%
Year High:33.55269.5%
Year Low:6.5039.7%
Volatility:13.00